SIM
CHE icon

Stelliam Investment Management’s Chemed CHE Stock Holding History

Stelliam Investment Management’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-382,500
Closed -$29.3M – 58
2013
Q4 		$29.3M Buy
+382,500
New +$28.2M 1.19% 47

Other funds holding CHE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Stelliam Investment Management's CHE Position: Q1 2014 in Review

Stelliam Investment Management sold out of Chemed (CHE) in Q1 2014, closing a stake of 382,500 shares — an estimated $29.3M sold.

Stelliam Investment Management first reported a position in CHE in Q4 2013 and held it in 1 quarter. The position peaked at $29.3M in Q4 2013. 194 funds tracked by Wall St. Rank hold CHE as of Q1 2014.

  • Stelliam Investment Management reported no remaining Chemed position as of Q1 2014 after selling out during the quarter.
  • Stelliam Investment Management sold 382,500 Chemed shares in Q1 2014, an estimated $29.3M.
  • Stelliam Investment Management first reported a position in Chemed in Q4 2013 and held it in 1 quarter.
  • Stelliam Investment Management's Chemed position peaked at $29.3M in Q4 2013.
  • 194 funds tracked by Wall St. Rank held Chemed as of Q1 2014.

Based on Stelliam Investment Management's 13F filing for Q1 2014, filed 14 May 2014.